沙特阿拉伯和阿联酋的乙型肝炎病毒感染：公共卫生挑战及其补救措施。

Hepatitis B virus infection in Saudi Arabia and the UAE: Public health challenges and their remedial measures.

机构信息

Liver Disease Research Centre, College of Medicine, King Saud University, P.O. Box 22480, Riyadh 11495, Saudi Arabia; Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, P.O. Box 9515, Jeddah 21423, Saudi Arabia.

Department of GI Endoscopy, Ibrahim Bin Hamad Obaidullah Hospital, Ras Al Khaimah, United Arab Emirates.

出版信息

J Infect Public Health. 2023 Sep;16(9):1410-1417. doi: 10.1016/j.jiph.2023.07.008. Epub 2023 Jul 20.

DOI:10.1016/j.jiph.2023.07.008

PMID:37482014

Abstract

BACKGROUND

Hepatitis B virus (HBV) infection is a major public health concern globally with higher prevalence in Middle Eastern countries. Both Saudi Arabia and the UAE face critical challenges in HBV treatment and management despite the implementation of a mass vaccination program. This review aimed to understand the gaps and unmet needs related to HBV infection, public health challenges associated with its diagnosis, and treatment barriers in Saudi Arabia and the UAE. Additionally, the review aimed to provide the best practices in the HBV care pathway for effective remedial measures and disease reduction.

METHODS

The literature search was done from Pubmed.

RESULTS

The lack of disease awareness and knowledge about disease transmission among patients and their family members and healthcare professionals, lack of proper screening, underdiagnosis, social stigma, lack of established referral system, and treatment cost are the primary barriers to HBV diagnosis and management.

CONCLUSION

Appropriate healthcare initiatives should be undertaken to lower the disease burden in Saudi Arabia and the UAE.

摘要

背景

乙型肝炎病毒（HBV）感染是一个全球性的主要公共卫生关注点，在中东国家更为普遍。尽管实施了大规模疫苗接种计划，但沙特阿拉伯和阿联酋在 HBV 治疗和管理方面仍面临严峻挑战。本综述旨在了解与 HBV 感染相关的差距和未满足的需求、与诊断相关的公共卫生挑战以及沙特阿拉伯和阿联酋的治疗障碍。此外，本综述旨在提供 HBV 护理途径的最佳实践，以采取有效补救措施和减少疾病。